Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.5610.988.726.2411.72

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202510.56
Mar202410.98
Mar20238.72
Mar20226.24
Mar202111.72

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 10.56
-3.83
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹126.6 Cr 46.4% 26.5% -65.8% Stock Analytics
ADANI ENTERPRISES ₹243,192.0 Cr 6.9% -9.4% -15.5% Stock Analytics
REDINGTON ₹16,167.1 Cr 3.7% -17.1% -14.7% Stock Analytics
HONASA CONSUMER ₹9,857.1 Cr 1.6% 4.5% 31.2% Stock Analytics
MMTC ₹8,526.0 Cr 9% 1.4% 8% Stock Analytics
LLOYDS ENTERPRISES ₹7,878.5 Cr 24.7% 11.6% 17.3% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

46.4%

26.5%

-65.8%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses